Vestal Point Capital »

Bright Minds Biosciences shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $38M 545k 70.20
2026-03-31 $36M 492k 72.97

More positions owned by Vestal Point Capital

BioMarin Pharmaceutical (BMRN)
Neurocrine Biosciences (NBIX)
Abivax SA Sponsored Ads (ABVX)
United Therapeutics Corporation (UTHR)
Enliven Therapeutics (ELVN)
Nurix Therapeutics (NRIX)
Bicara Therapeutics (BCAX)
Taysha Gene Therapies Com Shs (TSHA)
Arrowhead Pharmaceuticals (ARWR)
Abbott Laboratories (ABT)
Zimmer Holdings (ZBH)
Disc Medicine (IRON)
Monte Rosa Therapeutics (GLUE)
Insulet Corporation (PODD)
Ascendis Pharma A/S Ord Shs (ASND)

View all positions for Vestal Point Capital

Top funds holding Bright Minds Biosciences

Jupiter Topco
Henderson Group
Cormorant Asset Management
BlackRock
Vivo Capital
Vestal Point Capital
Braidwell
Driehaus Capital Management
Balyasny Asset Management
Adage Capital Partners GP
Point72 Asset Management
Deerfield Management Company
RA Capital Management
Parkman Healthcare Partners
MPM Oncology Impact Management

View all funds holding Bright Minds Biosciences